Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of 3 Dosages of Estriol After Continuous Vaginal Administration for 21 Days [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetic and pharmacodynamic study evaluating three vaginal estriol dosing regimens over 21 days in menopausal women; results completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Menopause

Drugs mentioned

• Estriol (estriol)

Snippet

Sponsor: Galeno Desenvolvimento de Pesquisas Clínicas | Conditions: Menopause | Phase 1 | Status: COMPLETED